Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children

Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial

(2015) Ki Wook Yun et al.   BMC INFECTIOUS DISEASES

Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated)

(2012) Akiko Kikukawa et al.   VACCINE

Estimated global incidence of Japanese encephalitis:

(2011) Grant Campbell et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Japanese Encephalitis in Travelers from Non-Endemic Countries, 1973–2008

(2010) Susan L. Hills et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Japanese Encephalitis in Travelers: Review of Cases and Seasonal Risk

(2009) Mads R. Buhl et al.   JOURNAL OF TRAVEL MEDICINE

Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age

(2009) A. Kaltenböck et al.   VACCINE